Skip to main content
  • EHA

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
    • About EHA
    • CME
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
The European Hematology Association Roadmap for European Hematology Research: a consensus documentThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology Research
Andreas Engert, Carlo Balduini, Anneke Brand, Bertrand Coiffier, Catherine Cordonnier, Hartmut Döhner, Thom Duyvené de Wit, Sabine Eichinger, Willem Fibbe, Tony Green, Fleur de Haas, Achille Iolascon, Thierry Jaffredo, Francesco Rodeghiero, Gilles Salles, Jan Jacob Schuringa
Haematologica February 2016 101: 115-208; doi:10.3324/haematol.2015.136739
Andreas Engert
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.engert@uni-koeln.de
Jan Jacob Schuringa
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Coiffier
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hartmut Döhner
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achille Iolascon
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Balduini
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Eichinger
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anneke Brand
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Cordonnier
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Fibbe
Universität zu Köln, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Balduini
IRCCS Policlinico San Matteo Foundation, Pavia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anneke Brand
Leids Universitair Medisch Centrum, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Coiffier
Université Claude Bernard, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Cordonnier
Hôpitaux Universitaires Henri Mondor, Créteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hartmut Döhner
Universitätsklinikum Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thom Duyvené de Wit
European Hematology Association, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Eichinger
Medizinische Universität Wien, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Fibbe
Leids Universitair Medisch Centrum, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tony Green
Cambridge Institute for Medical Research, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fleur de Haas
European Hematology Association, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achille Iolascon
Università Federico II di Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Jaffredo
Université Pierre et Marie Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Rodeghiero
Ospedale San Bortolo, Vicenza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Salles
Hospices Civils de Lyon/Université de Lyon, Pierre-Bénite, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Jacob Schuringa
Universitair Medisch Centrum Groningen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Jaffredo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Salles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Andreas Engert1⇑,
  2. Carlo Balduini2,
  3. Anneke Brand3,
  4. Bertrand Coiffier4,
  5. Catherine Cordonnier5,
  6. Hartmut Döhner6,
  7. Thom Duyvené de Wit7,
  8. Sabine Eichinger8,
  9. Willem Fibbe3,
  10. Tony Green9,
  11. Fleur de Haas7,
  12. Achille Iolascon10,
  13. Thierry Jaffredo11,
  14. Francesco Rodeghiero12,
  15. Gilles Salles13,
  16. Jan Jacob Schuringa14,
  17. the other authors of the EHA Roadmap for European Hematology Research
  1. 1Universität zu Köln, Cologne, Germany
  2. 2IRCCS Policlinico San Matteo Foundation, Pavia, Italy
  3. 3Leids Universitair Medisch Centrum, Leiden, the Netherlands
  4. 4Université Claude Bernard, Lyon, France
  5. 5Hôpitaux Universitaires Henri Mondor, Créteil, France
  6. 6Universitätsklinikum Ulm, Germany
  7. 7European Hematology Association, The Hague, the Netherlands
  8. 8Medizinische Universität Wien, Vienna, Austria
  9. 9Cambridge Institute for Medical Research, United Kingdom
  10. 10Università Federico II di Napoli, Italy
  11. 11Université Pierre et Marie Curie, Paris, France
  12. 12Ospedale San Bortolo, Vicenza, Italy
  13. 13Hospices Civils de Lyon/Université de Lyon, Pierre-Bénite, France
  14. 14Universitair Medisch Centrum Groningen, the Netherlands
  1. Correspondence: a.engert{at}uni-koeln.de
                    View Abstract
                    • Article
                    • Figures & Data
                    • Info & Metrics
                    • PDF
                    Loading

                    Data supplements

                    • Disclosures and Contributions

                      Files in this Data Supplement:

                      • Adobe PDF - 2015_136739-Disclosures_and_Contributions.pdf

                    ARTICLE FIGURES & DATA

                    Figures

                    • Tables
                    • Figure 1.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 1.

                      An overview of the current ‘normal’ hematopoiesis field and an outlook on where future research should be directed.

                    • Figure 2.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 2.

                      A roadmap for research into new technologies in anemias and related disorders.

                    • Figure 3.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 3.

                      A roadmap for research into dyserythropoietic and hypogenerative anemias.

                    • Figure 4.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 4.

                      Red blood cell membrane disorders.

                    • Figure 5.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 5.

                      Proposed priorities for European research on hereditary hemolytic anemias.

                    • Figure 6.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 6.

                      Synergistic activation of coagulation by contact and tissue factor pathways.

                    • Figure 7.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 7.

                      Venous thrombosis (VT) incidence increases with age. Incidence rates per 100,000 person-years with 95% confidence intervals. Data are derived from the Tromsø Study (1994–2012), in which 26,853 individuals were followed for a median of 17.7 years, and a total of 710 first VTs occurred.

                    • Figure 8.
                      • Download figure
                      • Open in new tab
                      • Download powerpoint
                      Figure 8.

                      Activation of the adaptive antigen-specific immune response. Potential targets for interventions to reduce Ab production or mitigate destruction. Potential interventions include high-dose IVIG and PDN (prednisolone).

                    Tables

                    • Figures
                    • Table 1.

                      Key priorities in a European Anemia Research Roadmap.

                      Table 1.
                    • Table 2.

                      Late-life anemia is frequent in the elderly. Numbers based on a cohort of 19,758 university hospital inpatients and outpatients.203

                      Table 2.
                    PreviousNext
                    Back to top

                    Vol 101 Issue 2

                    Haematologica: 101 (2)
                    • Table of Contents
                    • Table of Contents (PDF)
                    • About the Cover
                    • Index by author
                    Email

                    Thank you for your interest in spreading the word about Haematologica.

                    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

                    Enter multiple addresses on separate lines or separate them with commas.
                    The European Hematology Association Roadmap for European Hematology Research: a consensus documentThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Road…
                    (Your Name) has forwarded a page to you from Haematologica
                    (Your Name) thought you would like to see this page from the Haematologica web site.
                    Print
                    Citation Tools
                    The European Hematology Association Roadmap for European Hematology Research: a consensus documentThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology ResearchThe EHA Roadmap for European Hematology Research
                    Andreas Engert, Carlo Balduini, Anneke Brand, Bertrand Coiffier, Catherine Cordonnier, Hartmut Döhner, Thom Duyvené de Wit, Sabine Eichinger, Willem Fibbe, Tony Green, Fleur de Haas, Achille Iolascon, Thierry Jaffredo, Francesco Rodeghiero, Gilles Salles, Jan Jacob Schuringa, the other authors of the EHA Roadmap for European Hematology Research
                    Haematologica Feb 2016, 101 (2) 115-208; DOI: 10.3324/haematol.2015.136739

                    Citation Manager Formats

                    • BibTeX
                    • Bookends
                    • EasyBib
                    • EndNote (tagged)
                    • EndNote 8 (xml)
                    • Medlars
                    • Mendeley
                    • Papers
                    • RefWorks Tagged
                    • Ref Manager
                    • RIS
                    • Zotero

                    Share
                    Andreas Engert, Carlo Balduini, Anneke Brand, Bertrand Coiffier, Catherine Cordonnier, Hartmut Döhner, Thom Duyvené de Wit, Sabine Eichinger, Willem Fibbe, Tony Green, Fleur de Haas, Achille Iolascon, Thierry Jaffredo, Francesco Rodeghiero, Gilles Salles, Jan Jacob Schuringa, the other authors of the EHA Roadmap for European Hematology Research
                    Haematologica Feb 2016, 101 (2) 115-208; DOI: 10.3324/haematol.2015.136739
                    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
                    • Tweet Widget
                    • Facebook Like
                    • Alert me when this article is cited
                    • Alert me if a correction is posted

                    Jump To

                    • Article
                      • Abstract
                      • Introduction
                      • Milestones in hematology and the contribution from Europe
                      • European research policy
                      • The European Hematology Association Roadmap
                      • 1.1. Erythropoiesis
                      • 1.2. Myelopoiesis
                      • 1.3. Megakaryopoiesis
                      • 1.4. Lymphopoiesis
                      • 1.5. Hematopoietic stem cells
                      • 1.6. Developmental aspects of hematopoiesis
                      • 1.7. Mesenchymal and other stromal cells
                      • 1.8. Transcriptional/epigenetic networks
                      • 1.9. Reprogramming/induced pluripotent stem cells/embryonic stem cells
                      • 2.1. Hodgkin lymphoma
                      • 2.2. Diffuse large B-cell lymphoma and Burkitt lymphoma in adults and children
                      • 2.3. Mantle cell lymphoma
                      • 2.4. Follicular lymphoma
                      • 2.5. Marginal zone lymphoma: extranodal, nodal, and splenic forms
                      • 2.6. T-cell and NK-cell lymphoma
                      • 2.7. Lymphoma and immune deficiency (including AIDS, post-transplant, and drug-induced immunodeficiency)
                      • 2.8. Chronic lymphocytic leukemia and other chronic lymphoproliferative disorders
                      • 2.9. Acute lymphoblastic leukemia
                      • 2.10. Multiple myeloma and other plasma cell neoplasms
                      • 3.1. Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
                      • 3.2. Acute myeloid leukemia
                      • 3.3. Chronic myeloid leukemia
                      • 3.4. Myeloproliferative neoplasms
                      • 4.1. New technologies for anemia and related disorders
                      • 4.2. Iron-deficiency anemia
                      • 4.3. Dyserythropoietic and hyporegenerative anemias
                      • 4.4. Hemolytic anemias, including membrane and enzyme defects
                      • 4.5. Congenital bone marrow failure, aplastic anemias, and paroxysmal nocturnal hemoglobinuria
                      • 4.6. Thalassemia and congenital hemoglobinopathies
                      • 4.7. Iron overload disorders
                      • 4.8. Anemia in the elderly
                      • 4.9. Sickle cell disease
                      • 5.1. Congenital platelet disorders: number and function
                      • 5.2. Acquired non-immune thrombocytopenia and acquired disorders of platelet function
                      • 5.3. Primary and secondary immune thrombocytopenia and fetal neonatal alloimmune thrombocytopenia
                      • 5.4. Heparin-induced thrombocytopenia and other drug-dependent immune thrombocytopenias
                      • 5.5. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
                      • 6.1. Genomics in hemostasis
                      • 6.2. Novel mechanisms for coagulation activation
                      • 6.3. Venous thromboembolism
                      • 6.4. Venous thrombosis in aging populations
                      • 6.5. Bleeding disorders
                      • 6.6. Women, hemostasis, and thrombosis
                      • 7.1. Conventional blood products: indications and usage
                      • 7.2. Plasma-derived and recombinant human plasma proteins
                      • 7.3. Hemapheresis
                      • 7.4. Immunological transfusion complications: alloimmunization/transfusion-related immunomodulation/ hemovigilance
                      • 7.5. Blood-borne infections and hematologic patients: lines of research
                      • 7.6. Pathogen reduction of blood components
                      • 7.7. Toward large-scale production of blood cells for transfusion purposes
                      • 8.1. Infections in HSCT recipients
                      • 8.2. Infections in neutropenic patients
                      • 8.3. Infections in non-neutropenic patients other than hematopoietic stem cell transplantation recipients
                      • 8.4. Infections in primary immune deficiencies
                      • 8.5. Genetic predisposition factors for infection in hematology and hematopoietic stem cell transplantation patients
                      • 9.1. Allogeneic stem cell transplantation
                      • 9.2. Immune-based therapies for hematologic malignancies
                      • 9.3. The hematopoietic stem cell niche: regulation of hematopoietic stem cell function and significance for hematopoietic stem cell expansion
                      • 9.4. Human pluripotent stem cells: source of hematopoietic stem cells and hematopoietic progenitor cells
                      • 9.5. Advanced therapy medicinal products and other cell therapies
                      • Acknowledgments
                      • Appendix The authors of the European Hematology Association Roadmap for European Hematology Research
                      • Footnotes
                      • References
                    • Figures & Data
                    • Info & Metrics
                    • PDF

                    More in this TOC Section

                    Show more Opinion Article

                    Related Articles

                    Cited By...

                    What about you?
                    Tell us your interests and get all the new contents of Haematologica in advance

                     

                     

                    Navigate

                    • Home
                    • Current issue
                    • Ahead of print
                    • Archive
                    • Info for
                      • Authors
                      • Reviewers
                      • Advertisers
                      • Subscribers
                    • About us
                      • About Haematologica
                      • Editorial Board
                      • Our policies
                      • About EHA
                      • CME

                    For Authors

                    • Author guidelines
                    • Submit Manuscript
                    • Track Manuscript

                    For Reviewers

                    • Reviewer Guidelines
                    • Access Your Profile
                    • Access Your Tasks
                    • 2014 reviewers

                    For Advertisers

                    • Information For Advertising

                    Education

                    • Review Articles
                    • Guideline Articles
                    • EHA Education Book
                    • EHA Education Tools
                    • CME

                    More

                    • Rights & Permissions
                    • Advertising
                    • Alerts
                    • Feedback
                    • Contact
                    • App

                    EHA

                    • About EHA
                    • Become a member of EHA
                    • EHA events
                    • EHA education tools
                    • EHA Corporate Sponsors

                    Copyright © 2018 by the Ferrata Storti Foundation

                    ISSN 0390-6078 print

                    ISSN 1592-8721 online